Bone tumours
52 results
1 - 52
Intralesional treatment versus wide resection for central low‐grade chondrosarcoma of the long bones- Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy
- Radiotherapy for the palliation of painful bone metastases: Cochrane systematic review
- Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients
- Calcitonin for metastatic bone pain: Cochrane systematic review
- Interventions for the treatment of keratocystic odontogenic tumours
- Mannitol versus hypertonic saline for brain relaxation in patients undergoing craniotomy
- Add‐back therapy with GnRH analogues for uterine fibroids
- High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with first recurrence of Ewing sarcoma
- Interventions for central giant cell granuloma (CGCG) of the jaws
- High‐dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma
- Fluorine‐18‐fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma
- High‐dose chemotherapy and autologous haematopoietic stem cell rescue for children with high‐risk neuroblastoma
- Protons versus photons for the treatment of chordoma
- First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies
- Retinoic acid postconsolidation therapy for high‐risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation
- High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma
- Chemoradiation for advanced primary vulval cancer
- Combination chemotherapy for primary treatment of high‐risk gestational trophoblastic tumour
- Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer
- High‐dose therapy with autologous stem cell transplantation versus chemotherapy or immuno‐chemotherapy for follicular lymphoma in adults
- Prophylaxis for Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients
- Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia
- Interventions for treating AIDS‐associated Hodgkin´s lymphoma in treatment‐naive adults
- Systemic treatments for metastatic cutaneous melanoma
- Hormone replacement therapy for women previously treated for endometrial cancer
- Surgery for spontaneous supratentorial intracerebral haemorrhage
- Cell‐based therapies for amyotrophic lateral sclerosis/motor neuron disease
- Next‐generation sequencing for guiding matched targeted therapies in people with relapsed or metastatic cancer
- Hormone replacement therapy after surgery for epithelial ovarian cancer
- Interval brain imaging for adults with cerebral glioma
- Tumor necrosis factor (TNF) inhibitors for psoriatic arthritis
- Immunity after COVID‐19 vaccination in people with higher risk of compromised immune status: a scoping review
- Surgical removal versus retention for the management of asymptomatic disease‐free impacted wisdom teeth
- Interventions for the treatment of metastatic extradural spinal cord compression in adults
- Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer
- Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)
- Breast surgery for metastatic breast cancer
- Preoperative medical therapy before surgery for uterine fibroids